Mohamed Al Hajji, MD
Cardiovascular Disease · Morgantown, WVNPI 1184184210
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.2%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Boston Scientific at 26.9% of the total. Reporting peaked in 2024 at $2,147 and has fallen 51.4% since, to $1,044 in 2025.
Across 38 payments — averaging $98.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Abiomed$950
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$328
- Endotronix, Inc.$223
- Abbott$213
- Cook Incorporated$200
- plus $817 from 9 others
What the payments were for
- Grants$88224%
- Travel & lodging$95025%
- Food & beverage$1,69045%
- Education$2156%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $1,006 |
| Abiomed | 1 | $950 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $328 |
| Endotronix, Inc. | 2 | $223 |
| Abbott | 6 | $213 |
| Cook Incorporated | 1 | $200 |
| Heartflow, Inc. | 1 | $182 |
| AstraZeneca | 5 | $154 |
| E.r. Squibb & Sons, L.L.C. | 2 | $153 |
| Baxter Healthcare | 1 | $127 |
| Johnson & Johnson | 1 | $80 |
| Lantheus Medical Imaging, Inc. | 1 | $37 |
| Pfizer | 1 | $35 |
| Aurinia Pharma U.S., Inc. | 1 | $25 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$950
- FFRct$182
- AVVIGO Guidance System$144
- CORDELLA PULOMONARY ARTERY PRESSURE SENSOR$141
- ENSITE$134
- Renal - Acute$127
How this compares
$3,737 in reported general payments places this provider in the 60th percentile of 100 cardiovascular disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 40 | $749 |
| Atorvastatin Calcium | 23 | $209 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 15 | $199 |
| Metoprolol Tartrate | 13 | $22 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Morgantown
- Partho SenguptaMorgantown$131K
- Madhavi KadiyalaMorgantown$29K
- David CampseyMorgantown$21K
- Morgan LyonsMorgantown$7K
- Muchi Ditah ChobufoMorgantown$7K
- Raahat BansalMorgantown$6K
- Walid GharibMorgantown$6K
- David TinglerMorgantown$6K
- Yasmin HamiraniMorgantown$5K
- Ruby HavistinMorgantown$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.